• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine
  • Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

Pharma & Human Health

Pharma & Human Health

Leading immune-focused microbiome drug company taps Biose Industrie for manufacturing expertise

November 27, 2020 Staff Editor

Every microbiome-focused company has its own approach for discovering drug candidates—but rarely is the mechanism of action for a live biotherapeutic product (LBP) known from the outset. Microbiome pharma company ImmunoBiome, however, uses a unique […]

Pharma & Human Health

The Microbiome of Da Vinci’s Drawings

November 23, 2020 Staff Editor

The work of Leonardo Da Vinci is an invaluable heritage of the 15th century. From engineering to anatomy, the master paved the way for many scientific disciplines. But what else could the drawings of Da […]

Pharma & Human Health

Persephone Biosciences Initiates the ARGONAUT Study of Gut Microbiome-Linked Immune Modulation in Cancer Treatment Response

November 23, 2020 Staff Editor

Persephone Biosciences Inc., a biotechnology company that leverages real world data and artificial intelligence to design microbiome therapeutics and diagnostics to promote normal immune function and fight disease, today announced the initiation of the ARGONAUT […]

Finance

Galmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for Aramchol

November 20, 2020 Staff Editor

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) and MyBiotics Pharma Ltd. announced today they have entered into a research and development collaboration agreement to identify and optimize the selected microbiome repertoire associated with the response to Aramchol. […]

Finance

ADM Ventures Announces New Investment in Microbiome

November 9, 2020 Staff Editor

ADM Ventures, the corporate venture capital arm of ADM (NYSE: ADM), today announced its investment in Seventure’s Health For Life Capital (HFLC) Fund II. HFLC, based in Paris, is a leading venture capital fund dedicated […]

Finance

L’Oréal signs license agreement with Dutch biotech Micreos, world leader in targeted bacterial biotechnology

November 2, 2020 Staff Editor

L’Oréal and Micreos announced today the signature of a license agreement to join their expertise in biotechnology and the skin microbiome, the community of bacteria and microorganisms that live on the skin. Under the terms […]

Finance

Spain approves the use of the term “probiotic” in foods

November 2, 2020 Luis Gosálbez

Europe does not have a clear or harmonized regulatory framework on probiotics, and therefore decisions may be made on them by individual Member States. The general view by both European and National authorities is that […]

Finance

4D pharma plc announces merger with Longevity, a special purpose acquisition company (SPAC), and its intention to gain a NASDAQ listing

October 28, 2020 Staff Editor

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) – a novel class of drug derived from the microbiome – and Longevity Acquisition Corporation (NASDAQ: LOAC) (“Longevity”), a […]

Pharma & Human Health

Ingestible capsule that could help demystify the gut-brain axis

October 26, 2020 Staff Editor

Anyone who has experienced “butterflies in the stomach” before giving a big presentation will be unsurprised to learn there is a physical connection between their gut and their brain. Neuroscientists and medical professionals call this […]

Finance

Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners

October 23, 2020 Staff Editor

Solarea Bio, a biotech company based in Cambridge, MA developing microbial-based solutions to aid human health, announced today it has raised $11.2M in a Series A financing led by S2G Ventures and Bold Capital Partners, […]

Finance

MyBiotics Awarded 2 Million Euro Grant from the European Union

October 22, 2020 Staff Editor

MyBiotics Pharma Ltd., a microbiome therapeutics company, announced today that it was awarded 2.0 million Euros ($2.3 million) by the European Union as part of its Horizon 2020 Program. The grant will support the development of a […]

Posts navigation

« 1 2 3 … 44 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

Market Reports
October 26, 2020
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new [...]

Editor’s Choice

  • First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes
    September 25, 2020
  • Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infection
    August 10, 2020
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Market Reports
  • Pharma & Human Health
  • Phytobiome & Environment
  • Premium Content
  • Reports
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter